Controlling hydrogelation kinetics by peptide design for three-dimensional encapsulation and injectable delivery of cells
By Lisa A Haines-Butterick, K. Rajagopal, M. Branco, Daphne A. Salick, Ronak V. Rughani, Matthew Pilarz, M. Lamm, Darrin J. Pochan, J. Schneider. Proceedings of the National Academy of Sciences of the United States of America, 2007
600 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Molecular Medicine
View Paper: https://www.semanticscholar.org/paper/8b9a3259932947d4fc81ad52b57aaa8356ba0c26
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
- Melinda Larsen
- William P. Daley
- Sigrid A. Langhans
- Maria Farsari
- B. Chichkov
- M. Vamvakaki
- Sarah B. Peters
In Molecular Medicine
Citations in the corpus
- Three-Dimensional in Vitro Cell Culture Models in Drug Discovery and Drug Repositioning (2018, background): “A single acid substitution derivative of the MAX1 peptide, MAX8 (Haines-Butterick et al., 2007), with reduced gelation times has recently been reported to be compatible with liquid handling equipment making it suitable for high-throughput drug discovery (Worthington et al.”
- Extracellular matrix dynamics in development and regenerative medicine (2008, background): “, 2002) that forms either an ordered or random matrix, depending on external factors (Haines-Butterick et al., 2007; Nowak et al., 2002).”
- Cell Encapsulation in Biodegradable Hydrogels for Tissue Engineering Applications (2008, neutral): “This process enables an already formed cell-laden gel to be delivered in situ through a syringe and was successfully demonstrated with encapsulated MSCs. 75 Elastin-like peptides (ELPs) have been genetically engineered with precisely controlled sequences, molecular weights, and gelation temperatures”